Journey Medical Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Journey Medical stock has a consensus rating of "Strong Buy" and an average price target of $13.5. The average 1-year stock price forecast is 112.93% higher than the current stock price, while the lowest is $12 (+89.27%) and the highest is $16 (+152.37%).

Price Target: $13.5 (+112.93%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$12	$13.5	$13	$16
Change	+89.27%	+112.93%	+105.05%	+152.37%

* Price targets were last updated on May 14, 2026.

Analyst Ratings

The average analyst rating for Journey Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	4	4	4	4	4	4
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	4	4	4	4	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Scott Henry Alliance Global Partners	Alliance Global Partners	Buy Reiterates $16	Buy	Reiterates	$16	+152.37%	May 14, 2026
Thomas Flaten Lake Street	Lake Street	Buy Maintains $13	Buy	Maintains	$13	+105.05%	May 14, 2026
Brandon Folkes H.C. Wainwright	H.C. Wainwright	Buy Reiterates $13	Buy	Reiterates	$13	+105.05%	May 14, 2026
Mayank Mamtani B. Riley Securities	B. Riley Securities	Buy Reiterates $12	Buy	Reiterates	$12	+89.27%	Mar 26, 2026

Financial Forecast

Revenue This Year

82.62M

from 61.86M

33.57%

from 61.86M

Revenue Next Year

137.73M

from 82.62M

66.70%

from 82.62M

EPS This Year

n/a

from -

EPS Next Year

n/a

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	63.13M	73.67M	79.18M	56.13M	61.86M	82.62M
Revenue Growth	41.78%	16.69%	7.48%	-29.11%	10.20%	33.57%
Gross Profit	37.55M	42.89M	56.29M	35.26M	40.93M	51.50M
Gross Margin	59.48%	58.23%	71.09%	62.81%	66.17%	62.33%
Operating Income	-18.84M	-27.52M	1.07M	-13.68M	-8.17M	6.14M
Net Income	-43.99M	-29.63M	-3.85M	-14.67M	-11.43M	1.36M
Free Cash Flow	-4.25M	-24.51M	-4.79M	-18.48M	-8.35M	9.54M
No. Analysts	-	-	-	-	-	4

Revenue Forecast

Revenue	2026	2027	2028
High	86.3M
Avg	82.6M
Low	78.6M

Revenue Growth

Revenue Growth	2026	2027	2028
High	39.6%
Avg	33.6%
Low	27.1%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-
Low	-

EPS Growth

EPS Growth	2027	2028
High	-
Avg	-
Low	-